Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PneuMum: Pneumococcal Vaccination for Indigenous Mothers
NCT00714064Phase 3Completed
- Sponsor
- Menzies School of Health Research
- Start
- Jun 2006
- Primary completion
- Feb 2011
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of 23-valent pneumococcal polysaccharide vaccine in otitis media, pneumococcal infection, sponsored by Menzies School of Health Research. Started Jun 2006; status: completed.
02
Drugs
23-valent pneumococcal polysaccharide vaccine
03
Conditions
otitis mediapneumococcal infection
Beyond the preview
Go deeper on NCT00714064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00714064.